Lyophilized Drugs Market, by Drug Class (Anti-infective, Antineoplastic, Diuretics, Proton Pump Inhibitor, Anesthetic, Anticoagulant, NSAID’s, and Others), by Indication (Infectious Disease, Autoimmune Disease, Gastrointestinal Disease, Cancer, and Others), by Packaging Type (Vial, Injection, and Cartridge), and by region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Trends, and Forecast 2018 - 2026

  • Published On : Jul 2019 |
  • Pages : 208 Pages |
  • Format : CMI Insight PPT Format CMI Insight PDF Format

Global Lyophilized Drugs Market Insights

Lyophilization of the sterile injectable is necessary to maintain the stability of some unstable bulk ingredients. Lyophilization provides longer shelf life, from two to five years, to the molecule. Lyophilization also enables easy transportation of bulk drugs. Moreover, lyophilized drugs can be stored at room temperature. Manufacturers such as BUCHI Labortechnik AG, SP Scientific, and West Pharmaceutical Services, Inc. are focusing on development of lyophilization process to enhance production capacity of lyophilized drug.

Moreover, pharmaceutical companies are focusing on the development of highly advanced lyophilized drug delivery systems, in order to address or meet significant challenges such as multistep drug administration procedures, inconvenience administration of drugs through self-injection, risk of needlestick injuries, and others (lengthy dose preparation timings).

The global lyophilized drugs market is estimated to be valued at US$ 322.9 Billion in 2018, and is expected to witness a CAGR of 7.1% during the forecast period (2018–2026).

Figure 1. Global Lyophilized Drugs Market Share (%), By Drug Class, (2018 & 2026)

Lyophilized Drugs  | Coherent Market Insights

Source: Coherent Market Insights Analysis (2019)

Rising regulatory approvals for lyophilized drugs is expected to drive growth of the global lyophilized drugs market

Increasing regulatory approvals for wide range of lyophilized formulations for various disease conditions is expected to drive growth of lyophilized drugs market. For instance, in April 2014, GlaxoSmithKline plc received the U.S. Food and Drug Administration (FDA) approval for its Tanzeum (albiglutide lyophilized for injection), for subcutaneous use, as a once-weekly treatment for type 2 diabetes. Moreover, in September 2014, the U.S. Food and Drug Administration (FDA) approved a new formulation of Abilify Maintena (aripiprazole) for extended-release injectable suspension, a pre-filled dual-chamber syringe, developed by Otsuka Pharmaceutical Development & Commercialization, Inc. The drug is indicated for the treatment of schizophrenia in adults and in maintenance monotherapy treatment of bipolar I disorder in adults

Furthermore, increasing initiatives such as acquisitions by key players for advancement and distribution of anesthetics to various healthcare providing organizations is expected to significantly drive the lyophilized drugs market growth. For instance, in December 2018, North American Partners in Anesthesia (NAPA), a single-specialty anesthesia and perioperative management firm in the U.S., acquired certain assets of Aisthesis Partners in anesthesia care and its affiliated medical practices (‘Aisthesis’). Aisthesis provides its anesthesia services to 25 ambulatory surgical centers (ASCs), 3 hospitals, and 3 physician offices across four states in the U.S. and the District of Columbia. Thus, this initiative may contribute to increasing demand for the lyophilized anesthetics drug, which in turn is expected to show significant market growth.

Global Lyophilized Drugs Market - Restraints

The growth of the lyophilized drugs market can be hindered due to increasing number of product recalls for lyophilized drugs and packaging type. In January 2019, U.S. Food and Drug Administration issued a product recall notice for three lots of Vecuronium Bromide for Injection, 10 mg (lyophilized powder), and one lot of Vecuronium Bromide for Injection, 20 mg (lyophilized powder), developed by Sun Pharmaceutical Industries, Inc. The product has been recalled due to the presence of glass particulate in the product.

Global Lyophilized Drugs Market- Regional Analysis

North America is expected to witness lucrative growth in the global lyophilized drugs market, owing to increasing prevalence of diseases in the U.S. Presence of major manufacturers such as Fresenius Kabi, Merck & Co. Inc., and Amneal Pharmaceutical who are extensively engaged in manufacturing of lyophilized injectable is contributing to growth of the North America Lyophilized Drugs Market. Moreover, increasing product approvals by regulatory authorities in North America is expected to bolster growth of North America Lyophilized Drugs Market. For instance, in December 2015, Aurobindo Pharma Limited received the U.S. FDA approval to manufacture and market Methylprednisolone Sodium Succinate Injection USP (lyophilized drug), 40 mg/vial, 125 mg/vial, 500 mg/vial, and 2 g/vial.

Asia Pacific is also expected to drive growth of the global lyophilized drugs market, owing to initiatives by key players to expand their production facility, in order to manufacture lyophilized drugs in large scale. For instance, in July 2017, Alembic Pharmaceuticals, based in India, opened its new manufacturing facility in Panelav, Gujarat, India. The new site has manufacturing capacity of around 20 million vials of liquid injectable and lyophilized concentrations.

Europe is expected to experience growth owing to continuous advancements in lyophilization processes and increasing launches of lyophilized drugs. For instance, in April 2017, BÜCHI Labortechnik AG introduced the modular Lyovapor platform for freeze drying (lyophilization). The new product offers continuous sublimation.

Figure 2: Global Lyophilized Drugs Market Share (%), By Region, (2018 & 2026)

Lyophilized Drugs  | Coherent Market Insights

Source: Coherent Market Insights Analysis (2019)

Key players operating in the global lyophilized drugs market include Sanofi S.A, Merck & Co., Inc., Fresenius Kabi USA, LLC., Ciron Drugs & Pharmaceuticals Pvt Ltd., GlaxoSmithKline plc., Mylan NV., Pfizer, Inc., Amneal Pharmaceuticals LLC, Otsuka Holdings Co., Ltd.  (Otsuka Pharmaceutical Co., Ltd.), and BTG Plc.

Lyophilization or freeze drying is the process, in which the water content in the drug sample is frozen, followed by its removal from the sample. In the process of lyophilization, the frozen water content changes directly from solid to vapor without passing through a liquid phase. The process includes three steps: Freezing, primary drying (sublimation), and secondary drying (desorption). Pharmaceutical products that undergo lyophilization process include bulk pharmaceutical/biopharmaceutical ingredient (API), protein, collagen, peptide, oligonucleotide, enzymes, and mAbs.

Market Dynamics

Lyophilized drugs are majorly used to treat infectious diseases and autoimmune diseases. Thus, increasing prevalence of infectious diseases is expected to aid in growth of the global lyophilized drugs market. For instance, according to The Lancet Infectious Diseases (report) published in 2017, fungal infection affects over a billion people worldwide, resulting in around 11.5 million life-threatening infections and over 1.5 million deaths, annually. The number of lyophilized drugs such as Amphotericin B (Mycoflu), Vonfung NDD (voriconazole,) and other antifungal lyophilized drugs are available in market for treating fungal infections.

Lyophilized drug manufacturers are looking forward to expand their facilities to produce lyophilized drugs on large scale, which in turn contributing to growth of the global lyophilized drugs market. For instance, on January 2017, AB Technologies (AB) announced investment of US$ 10.5 million to build a new 23,000-square-foot manufacturing facility at its site in Bloomington, Indiana. The new facility will include manufacturing area for formulating, filling, lyophilizing, and packaging drugs for early-phase clinical trial studies. Moreover, AB Technologies (AB) added aseptic filling and lyophilizer loading systems into the new facility.

Major pharmaceutical manufacturers are engaged in the development and launching of innovative lyophilized drugs, which is expected to drive the global lyophilized drugs market growth. For instance, in November 2018, Xellia Pharmaceuticals launched Vancomycin Hydrochloride for Injection, USP within the U.S. market. Vancomycin Hydrochloride for Injection is lyophilized powder to treat or prevent infections that are caused by bacteria

Key features of the study:

  • This report provides in-depth analysis of the global lyophilized drugs market, market size (US$ Mn), and compound annual growth rate (CAGR %) over the forecast period (2018–2026), considering 2017, as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new technology launches or approval, market trends, regional outlook, and competitive strategies adopted by the leading players
  • It profiles leading players in the global lyophilized drugs market based on the following parameters – company overview, financial performance, Technology portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key players covered as a part of this study include Sanofi S.A, Merck & Co., Inc., Fresenius Kabi USA, LLC., Ciron Drugs & Pharmaceuticals Pvt Ltd., GlaxoSmithKline plc., Mylan NV., Pfizer, Inc., Amneal Pharmaceuticals LLC, Otsuka Holdings Co., Ltd.  (Otsuka Pharmaceutical Co., Ltd.), and BTG Plc.
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future technology launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
  • The global lyophilized drugs market report caters to various stakeholders in this market, including investors, technology manufacturers, distributors, and suppliers for global Lyophilized Drugs Market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:

  • Global Lyophilized Drugs Market, By Drug Class:
    • Anti-infective
    • Antineoplastic
    • Diuretics
    • Proton Pump Inhibitor
    • Anesthetic
    • Anticoagulant
    • NSAID’s
    • Others
  • Global Lyophilized Drugs Market, By Indication:
    • Infectious Disease
    • Autoimmune Disease
    • Gastrointestinal Disease
    • Cancer
    • Others
  • Global Lyophilized Drugs Market, By Packaging Type:
    • Vial
    • Injection
    • Cartridge
  • Global Lyophilized Drugs Market, By Region:
    • North America
      • By Country:
        • U.S.
        • Canada
      • By Drug Class:
        • Anti-infective
        • Antineoplastic
        • Diuretics
        • Proton Pump Inhibitor
        • Anesthetic
        • Anticoagulant
        • NSAID’s
        • Others
      • By Indication:
        • Infectious Disease
        • Autoimmune Disease
        • Gastrointestinal Disease
        • Cancer
        • Others
      • By Packaging Type:
        • Vial
        • Injection
        • Cartridge
    • Europe
      • By Country:
        • U.K.
        • Germany
        • Italy
        • Spain
        • France
        • Russia
        • Rest of Europe
      • By Drug Class:
        • Anti-infective
        • Antineoplastic
        • Diuretics
        • Proton Pump Inhibitor
        • Anesthetic
        • Anticoagulant
        • NSAID’s
        • Others
      • By Indication:
        • Infectious Disease
        • Autoimmune Disease
        • Gastrointestinal Disease
        • Cancer
        • Others
      • By Packaging Type:
        • Vial
        • Injection
        • Cartridge
    • Asia Pacific
      • By Country:
        • Australia
        • India
        • China
        • Japan
        • ASEAN
        • South Korea
        • Rest of Asia Pacific
      • By Drug Class:
        • Anti-infective
        • Antineoplastic
        • Diuretics
        • Proton Pump Inhibitor
        • Anesthetic
        • Anticoagulant
        • NSAID’s
        • Others
      • By Indication:
        • Infectious Disease
        • Autoimmune Disease
        • Gastrointestinal Disease
        • Cancer
        • Others
      • By Packaging Type:
        • Vial
        • Injection
        • Cartridge
    • Latin America
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
      • By Drug Class:
        • Anti-infective
        • Antineoplastic
        • Diuretics
        • Proton Pump Inhibitor
        • Anesthetic
        • Anticoagulant
        • NSAID’s
        • Others
      • By Indication:
        • Infectious Disease
        • Autoimmune Disease
        • Gastrointestinal Disease
        • Cancer
        • Others
      • By Packaging Type:
        • Vial
        • Injection
        • Cartridge
    • Middle East
      • By Country/Region:
        • GCC
        • Israel
        • Rest of Middle East
      • By Drug Class:
        • Anti-infective
        • Antineoplastic
        • Diuretics
        • Proton Pump Inhibitor
        • Anesthetic
        • Anticoagulant
        • NSAID’s
        • Others
      • By Indication:
        • Infectious Disease
        • Autoimmune Disease
        • Gastrointestinal Disease
        • Cancer
        • Others
      • By Packaging Type:
        • Vial
        • Injection
        • Cartridge
    • Africa
      • By Country/Region:
        • South Africa
        • Central Africa
        • North Africa
      • By Drug Class:
        • Anti-infective
        • Antineoplastic
        • Diuretics
        • Proton Pump Inhibitor
        • Anesthetic
        • Anticoagulant
        • NSAID’s
        • Others
      • By Indication:
        • Infectious Disease
        • Autoimmune Disease
        • Gastrointestinal Disease
        • Cancer
        • Others
      • By Packaging Type:
        • Vial
        • Injection
        • Cartridge
  • Company Profiles
    • Sanofi S.A *
      • Company Overview
      • Technology Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • Merck & Co., Inc.
    • Fresenius Kabi USA, LLC.
    • Ciron Drugs & Pharmaceuticals Pvt Ltd.
    • GlaxoSmithKline plc.
    • Mylan NV.
    • Pfizer, Inc.
    • Amneal Pharmaceuticals LLC
    • Otsuka Holdings Co., Ltd.  (Otsuka Pharmaceutical Co., Ltd.)
    • BTG Plc.

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Overview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Drug Class
      • Market Snippet, By Indication
      • Market Snippet, By Packaging Type
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Market Trends
    • Key Developments
    • Technology Advancements
    • Historical Overview
    • Merger and Acquisition
    • Regulatory Scenario
    • PORTER’S Five Forces
    • PEST Analysis
  4. Global Lyophilized Drugs Market, By Drug Class, 2016 – 2026, (US$ Million)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Anti-infective
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • Antineoplastic
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • Diuretics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • Proton Pump Inhibitor
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • Anesthetic
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • Anticoagulant
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • NSAID’s
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
  5. Global Lyophilized Drugs Market, By Indication, 2016 – 2026, (US$ Million)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Infectious Disease
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • Autoimmune Disease
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • Gastrointestinal Disease
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • Cancer
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
  6. Global Lyophilized Drugs Market, By Packaging Type, 2016 – 2026, (US$ Million)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Vials
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • Syringes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • Cartridge
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
  7. Global Lyophilized Drugs Market, By Region, 2016 – 2026, (US$ Million)
    • Introduction
      • Market Share Analysis, By Region, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, By Region, 2017 – 2026
      • Regional Trends
    • North America
      • Market Size and Forecast, By Drug Class, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Indication, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Packaging Type, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast, By Drug Class, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Indication, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Packaging Type, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Drug Class, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Indication, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Packaging Type, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
        • China
        • Japan
        • India
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast, By Drug Class, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Indication, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Packaging Type, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Middle East
      • Market Size and Forecast, By Drug Class, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Indication, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Packaging Type, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Country/Region, 2016 – 2026, (US$ Million)
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Drug Class, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Indication, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Packaging Type, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Country/Region, 2016 – 2026, (US$ Million)
        • Northern Africa
        • Central Africa
        • South Africa
  8. Competitive Landscape
    • Heat Map Analysis
    • Company Profiles
      • Sanofi S.A.
        • Company Overview
        • Technology Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Merck & Co., Inc.
        • Company Overview
        • Technology Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Fresenius Kabi USA, LLC.
        • Company Overview
        • Technology Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Ciron Drugs & Pharmaceuticals Pvt Ltd.
        • Company Overview
        • Technology Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • GlaxoSmithKline plc.
        • Company Overview
        • Technology Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Mylan NV.
        • Company Overview
        • Technology Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Pfizer, Inc.
        • Company Overview
        • Technology Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Amneal Pharmaceuticals LLC
        • Company Overview
        • Technology Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Otsuka Holdings Co., Ltd.  (Otsuka Pharmaceutical Co., Ltd.)
        • Company Overview
        • Technology Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • BTG Plc.
        • Company Overview
        • Technology Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
        •  
    • Analyst Views
  9. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 35 market data tables and 38 figures on "Lyophilized Drugs Market” - Global forecast to 2026”.

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.